In our study, we also demonstrated that co-treatment with MWCNTs and PbAc may elicit their hepatotoxicity to NAFLD mice via inhibiting the AMPK/PPAR-γ pathway. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.